S & T Bank »

Royalty Pharma shares owned by S & T Bank

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by S & T Bank from 13F filings

Historical chart of S & T Bank investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by S & T Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by S & T Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $282 8 35.25

More positions owned by S & T Bank

Sei Exchange Traded Funds Select Intl Equi (SEIE)
Sei Exchange Traded Funds Enhanced Us Lrg (SEIM)
Sei Exchange Traded Funds Enhanced Us Lrg (SEIV)
Flex Ord (FLEX)
S&T Ban (STBA)
Western Digital (WDC)
InterDigital (IDCC)
Corcept Therapeutics Incorporated (CORT)
AECOM Technology Corporation (ACM)
F5 Networks (FFIV)
Abbvie (ABBV)
Sei Exchange Traded Funds Select Small Cap (SEIS)
AmerisourceBergen (COR)
Cummins (CMI)
Sei Exchange Traded Funds Enhanced Us Lrg (SEIQ)

View all positions for S & T Bank

Top funds holding Royalty Pharma

Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Geode Capital Management
Caledonia
Victory Capital Management
Jane Street
Northern Trust
Norges Bank Investment Management
Patient Capital Management

View all funds holding Royalty Pharma